Diagnosis and Treatment of Eosinophilic Esophagitis

Alex Straumann, David A Katzka

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Eosinophilic esophagitis (EoE) is a new disease. It is caused by a T-helper type 2 cell response to food antigens in contact with the esophageal mucosa. Although no single feature defines EoE, a constellation of compatible demographic, clinical, endoscopic, and histologic findings establish the diagnosis. Children present with symptoms and endoscopic patterns characteristic of inflammation, whereas adolescents and adults have manifestations of fibrosis and gross esophageal strictures. Clinical and endoscopic scoring systems have helped to standardize diagnosis. There is controversy in EoE research over the optimal endpoint for treatment. Although the most common endpoint is a reduced number of eosinophils in biopsies, changes in symptoms and endoscopic features are becoming important targets of therapy. We should improve our understanding of EoE progression and the need for maintenance therapy, and continue development of diagnostic tools that avoid endoscopy and biopsy analyses to more easily monitor disease activity.

Original languageEnglish (US)
Pages (from-to)346-359
Number of pages14
JournalGastroenterology
Volume154
Issue number2
DOIs
StatePublished - Jan 1 2018

Fingerprint

Eosinophilic Esophagitis
Biopsy
Esophageal Stenosis
Th2 Cells
Therapeutics
Eosinophils
Endoscopy
Fibrosis
Demography
Inflammation
Antigens
Food
Research

Keywords

  • Eosinophilic Esophagitis
  • Esophagitis
  • Esophagus

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Diagnosis and Treatment of Eosinophilic Esophagitis. / Straumann, Alex; Katzka, David A.

In: Gastroenterology, Vol. 154, No. 2, 01.01.2018, p. 346-359.

Research output: Contribution to journalArticle

Straumann, Alex ; Katzka, David A. / Diagnosis and Treatment of Eosinophilic Esophagitis. In: Gastroenterology. 2018 ; Vol. 154, No. 2. pp. 346-359.
@article{af8647d8f7a14402bb50cfbe30688f2e,
title = "Diagnosis and Treatment of Eosinophilic Esophagitis",
abstract = "Eosinophilic esophagitis (EoE) is a new disease. It is caused by a T-helper type 2 cell response to food antigens in contact with the esophageal mucosa. Although no single feature defines EoE, a constellation of compatible demographic, clinical, endoscopic, and histologic findings establish the diagnosis. Children present with symptoms and endoscopic patterns characteristic of inflammation, whereas adolescents and adults have manifestations of fibrosis and gross esophageal strictures. Clinical and endoscopic scoring systems have helped to standardize diagnosis. There is controversy in EoE research over the optimal endpoint for treatment. Although the most common endpoint is a reduced number of eosinophils in biopsies, changes in symptoms and endoscopic features are becoming important targets of therapy. We should improve our understanding of EoE progression and the need for maintenance therapy, and continue development of diagnostic tools that avoid endoscopy and biopsy analyses to more easily monitor disease activity.",
keywords = "Eosinophilic Esophagitis, Esophagitis, Esophagus",
author = "Alex Straumann and Katzka, {David A}",
year = "2018",
month = "1",
day = "1",
doi = "10.1053/j.gastro.2017.05.066",
language = "English (US)",
volume = "154",
pages = "346--359",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Diagnosis and Treatment of Eosinophilic Esophagitis

AU - Straumann, Alex

AU - Katzka, David A

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Eosinophilic esophagitis (EoE) is a new disease. It is caused by a T-helper type 2 cell response to food antigens in contact with the esophageal mucosa. Although no single feature defines EoE, a constellation of compatible demographic, clinical, endoscopic, and histologic findings establish the diagnosis. Children present with symptoms and endoscopic patterns characteristic of inflammation, whereas adolescents and adults have manifestations of fibrosis and gross esophageal strictures. Clinical and endoscopic scoring systems have helped to standardize diagnosis. There is controversy in EoE research over the optimal endpoint for treatment. Although the most common endpoint is a reduced number of eosinophils in biopsies, changes in symptoms and endoscopic features are becoming important targets of therapy. We should improve our understanding of EoE progression and the need for maintenance therapy, and continue development of diagnostic tools that avoid endoscopy and biopsy analyses to more easily monitor disease activity.

AB - Eosinophilic esophagitis (EoE) is a new disease. It is caused by a T-helper type 2 cell response to food antigens in contact with the esophageal mucosa. Although no single feature defines EoE, a constellation of compatible demographic, clinical, endoscopic, and histologic findings establish the diagnosis. Children present with symptoms and endoscopic patterns characteristic of inflammation, whereas adolescents and adults have manifestations of fibrosis and gross esophageal strictures. Clinical and endoscopic scoring systems have helped to standardize diagnosis. There is controversy in EoE research over the optimal endpoint for treatment. Although the most common endpoint is a reduced number of eosinophils in biopsies, changes in symptoms and endoscopic features are becoming important targets of therapy. We should improve our understanding of EoE progression and the need for maintenance therapy, and continue development of diagnostic tools that avoid endoscopy and biopsy analyses to more easily monitor disease activity.

KW - Eosinophilic Esophagitis

KW - Esophagitis

KW - Esophagus

UR - http://www.scopus.com/inward/record.url?scp=85041080880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041080880&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2017.05.066

DO - 10.1053/j.gastro.2017.05.066

M3 - Article

C2 - 28756235

AN - SCOPUS:85041080880

VL - 154

SP - 346

EP - 359

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 2

ER -